vimarsana.com

Latest Breaking News On - Analyst recommendations for privia health group - Page 3 : vimarsana.com

Privia Health Group (NASDAQ:PRVA) Price Target Cut to $25 00

Privia Health Group (NASDAQ:PRVA – Get Free Report) had its price target lowered by analysts at Evercore ISI from $26.00 to $25.00 in a report issued on Wednesday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Evercore ISI’s target price points to a potential upside of 13.48% from the company’s current […]

Privia Health Group, Inc (NASDAQ:PRVA) Given Average Recommendation of Moderate Buy by Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine brokerages that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average […]

Privia Health Group (NASDAQ:PRVA) Rating Lowered to Neutral at Bank of America

Bank of America lowered shares of Privia Health Group (NASDAQ:PRVA – Free Report) from a buy rating to a neutral rating in a research report released on Thursday, MarketBeat Ratings reports. Bank of America currently has $21.00 price target on the stock, down from their previous price target of $27.00. PRVA has been the topic […]

Privia Health Group, Inc (NASDAQ:PRVA) Receives $34 22 Average PT from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average twelve-month […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.